Cargando…
Chronic Antibiotic-Refractory Pouchitis: Management Challenges
BACKGROUND: Pouchitis is the most common long-term complication in patients with ulcerative colitis who underwent restorative proctocolectomy with ileal pouch-anal anastomosis. The incidence of acute pouchitis is 20% after 1 year and up to 40% after 5 years. Chronic antibiotic-refractory pouchitis d...
Autores principales: | Outtier, An, Ferrante, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213947/ https://www.ncbi.nlm.nih.gov/pubmed/34163205 http://dx.doi.org/10.2147/CEG.S219556 |
Ejemplares similares
-
Vedolizumab for chronic antibiotic-refractory pouchitis
por: Singh, Amandeep, et al.
Publicado: (2019) -
Hyperbaric oxygen therapy for chronic antibiotic-refractory ischemic pouchitis
por: Nyabanga, Custon T, et al.
Publicado: (2017) -
The role of antibiotics and probiotics in pouchitis
por: Gionchetti, Paolo, et al.
Publicado: (2012) -
Use of vedolizumab in a patient with chronic and refractory pouchitis
por: Orfanoudaki, Eleni, et al.
Publicado: (2018) -
One-year infliximab administration for the treatment of chronic refractory pouchitis
por: Viazis, Nikos, et al.
Publicado: (2011)